Mohamed Ismail Abdul Aziz

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Locally Advanced

Hodgkin Lymphoma

Small Cell Lung Cancer

Top Venues

Journal of medical economics

Expert review of pharmacoeconomics & outcomes research

The Journal of asthma : official journal of the Association for the Care of Asthma

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Boon Piang Cher, Sharon Goh, Mohamed Ismail Abdul Aziz, Grace Wong, Raymond Ng Chee Hui, Benjamin Shao-Kiat Ong, Kwong-Hoe Ng
Cost-utility analysis of sacituzumab govitecan versus chemotherapy for the treatment of metastatic triple-negative breast cancer in Singapore. Expert review of pharmacoeconomics & outcomes research 24 (2) (2024)
Boon Piang Cher, Sharon Goh, Mohamed Ismail Abdul Aziz, Grace Wong, Raymond Ng Chee Hui, Benjamin Shao-Kiat Ong, Kwong-Hoe Ng
Cost-utility analysis of sacituzumab govitecan versus chemotherapy for the treatment of metastatic triple-negative breast cancer in Singapore. Expert review of pharmacoeconomics & outcomes research 24 (2) (2024)
Boon Piang Cher, Sharon Goh, Mohamed Ismail Abdul Aziz, Grace Wong, Raymond Ng Chee Hui, Benjamin Shao-Kiat Ong, Kwong-Hoe Ng
Cost-utility analysis of sacituzumab govitecan versus chemotherapy for the treatment of metastatic triple-negative breast cancer in Singapore. Expert review of pharmacoeconomics & outcomes research (2023)
Xin Yi Wong, Wee Joo Chng, Mohamed Ismail Abdul Aziz, Kwong Ng
Cost-effectiveness of daratumumab in combination with lenalidomide and dexamethasone for relapsed and/or refractory multiple myeloma. Expert review of pharmacoeconomics & outcomes research 22 (2) (2021)
Boon Piang Cher, Kar Yee Gan, Mohamed Ismail Abdul Aziz, Liang Lin, William Ying Khee Hwang, Limei Michelle Poon, Kwong Ng
Cost utility analysis of tisagenlecleucel vs salvage chemotherapy in the treatment of relapsed/refractory diffuse large B-cell lymphoma from Singapore's healthcare system perspective. Journal of medical economics 23 (11) (2020)
Lydia Pui Yee Loke, Soo-Chin Lee, Fiona Pearce, Mohamed Ismail Abdul Aziz, Mohamed Ismail Abdul Aziz
Cost-effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore. Cancer reports (Hoboken, N.J.) 4 (1) (2020)
Mohamed Ismail Abdul Aziz, Ling Eng Tan, Wan Hui Gloria Tan, Chee Keong Toh, Lydia Pui Yee Loke, Fiona Pearce, Kwong Ng
Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer. Journal of medical economics 23 (9) (2020)
Sil-Ling Pruis, Yunjoo Karris Jeon, Fiona Pearce, Bernard Yu-Hor Thong, Mohamed Ismail Abdul Aziz
Cost-effectiveness of sequential urate lowering therapies for the management of gout in Singapore. Journal of medical economics 23 (8) (2020)
Mohamed Ismail Abdul Aziz, Wayne Yong Xiang Foo, Chee Keong Toh, Wan-Teck Lim, Kwong Ng
Cost-effectiveness analysis of osimertinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small cell lung cancer in Singapore. Journal of medical economics 23 (11) (2020)
Ling Eng Tan, Wan Hui Gloria Tan, Mohamed Ismail Abdul Aziz, Mariko Siyue Koh, Tunn Ren Tay, Fiona Pearce, Mohamed Ismail Abdul Aziz
Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore. The Journal of asthma : official journal of the Association for the Care of Asthma (2020)